| [1] |
Li YQ, Zhou YB, Yang LJ. Structural feature and biological function of PPP2R5C gene[J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2009, 17(5): 1127-9. [李扬秋, 周羽竝, 杨力建. PPP2R5C 基因结构特点和生物学功能[J]. 中国实验血液学杂志, 2009, 17 (5): 1127-9.]
|
| [2] |
Li HH, Cai X, Shouse GP, et al. A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55[J]. EMBO J, 2007, 26(2): 402-11.
|
| [3] |
Chen Y, Zheng HT, Chen SH, et al. Distribution of the transcripts of PPP2R5C gene in healthy individuals and hematological malignance patients[J]. Ji’nan Da Xue Xue Bao(Yi Xue Ban), 20 10, 31(6): 550-4. [陈宇, 郑海涛, 陈少华, 等. PPP2R5C转录本 在正常人和血液肿瘤病人中的分布情况[J]. 暨南大学学报（医 学版） , 2010, 31(6): 550-4.]
|
| [4] |
Zheng H, Chen Y, Chen S, et al. Expression and distribution of the PPP2R5C gene in leukemia[J]. J Hematol Oncol, 2011, 4: 21.
|
| [5] |
Shen Q, Liu S, Chen Y, et al. Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation[J]. J Hematol Oncol, 2013, 6: 64.
|
| [6] |
Chen Y, Liu S, Shen Q, et al. Differential gene expression profiles of PPP2R5C-siRNA- treated malignant T cells [J]. DNA Cell Biol, 2013, 32(10): 573-81.
|
| [7] |
Tanikawa C, Nakagawa H, Furukawa Y, et al. CLCA2 as a p53- Inducible Senescence Mediator[J]. Neoplasia, 2012, 14(2): 141-9.
|
| [8] |
Vigneron A, Vousden KH. p53 and Mdm2: an auld alliance[J]. Cell Cycle, 2010, 9(5): 865-6.
|
| [9] |
Zhang Z, Li M, Wang H, et al. Antisense therapy targeting MDM2 oncogene in prostate cancer: effects on proliferation, apoptosis, multiple gene expression, and chemotherapy[J]. Proc Natl Acad Sci U S A, 2003,100(20): 11636-41.
|
| [10] |
Hou X, Qin SK, Ou YR, et al. Expressions and relevance of MDM2 and PTEN in bile duct carcinoma[J]. Zhong Liu Fang Zhi Yan Jiu, 2014, 41(6): 610-3. [侯鑫, 秦叔逵, 欧玉荣, 等. 胆管癌 中MDM2和PTEN的表达及其相关性[J]. 肿瘤防治研究, 2014, 41 (6): 610-3.]
|
| [11] |
Zhang L, Huang NJ, Chen C, et al. Ubiquitylation of p53 by the APC/C inhibitor Trim39[J]. Proc Natl Acad Sci U S A, 2012, 10 9(51): 20931-6.
|
| [12] |
Shouse GP, Cai X, Liu X. Serine 15 phosphorylation of p53 directs its interaction with B56gamma and the tumor suppressor activity of B56gamma-specific protein phosphatase 2A[J]. Mol Cell Biol, 20 08, 28(1): 448-56.
|
| [13] |
Shouse GP, Nobumori Y, Panowicz MJ, et al. ATM-mediated phosphorylation activates the tumor-suppressive function of B56γ- PP2A[J]. Oncogene, 2011, 30(35): 3755-65.
|
| [14] |
Chen Y, Gridley T. Compensatory regulation of the Snai1 and Snai2 genes during chondrogenesis[J]. J Bone Miner Res, 2013, 28 (6): 1412-21.
|
| [15] |
Nobumori Y, Shouse GP, Wu Y, et al. B56γ tumor-associated mutations provide new mechanisms for B56γ-PP2A tumor suppressor activity[J]. Mol Cancer Res, 2013, 11(9): 995-1003.
|
下载:
